Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-19T07:56:19.487Z Has data issue: false hasContentIssue false
  • English
  • Français

Ondansetron or droperidol for prophylaxis of nausea and vomiting after intrathecal morphine

Published online by Cambridge University Press:  04 April 2006

A. J. Peixoto ,
M. F. Celich ,
L. Zardo  and
A. J. Peixoto Filho
A. J. Peixoto
Affiliation:
Hospital de Caridade, Department of Anaesthesiology, Erechim, Brazil
M. F. Celich
Affiliation:
Hospital de Caridade, Department of Anaesthesiology, Erechim, Brazil
L. Zardo
Affiliation:
Hospital de Caridade, Department of Anaesthesiology, Erechim, Brazil
A. J. Peixoto Filho
Affiliation:
Yale University School of Medicine, Section of Nephrology, New Haven Renal Section, VA Connecticut Healthcare System, West Haven, USA
Get access

Extract

Summary

Background and objective: There is a controversy regarding the best drug for prevention of nausea and vomiting in patients receiving intrathecal morphine. The aim of this study was to examine efficacy and tolerability of droperidol compared with ondansetron for the prevention of morphine-induced nausea and vomiting. Methods: In a randomized, placebo-controlled trial, 120 women undergoing Caesarean section under spinal anaesthesia with intrathecal morphine 0.1 mg received intravenous ondansetron 4 mg (n = 40), droperidol 1.25 mg (n = 40) or saline (n = 40) immediately after umbilical-cord clamping. Nausea and vomiting were graded according to intensity at 1, 2, 4, 6, 12 and 24 h. Results: Nausea or vomiting occurred in 14 patients (35%) in the placebo group, 4 (10%) in the ondansetron group and 10 (25%) in the droperidol group; the difference between ondansetron and placebo was statistically significant (P = 0.007). Eleven of the 14 placebo patients (27.5%) vomited, compared with none of the 4 ondansetron patients (vs. placebo, P = 0.0004) and 5 of the droperidol patients (vs. placebo, P = 0.18). Three of the 14 placebo patients (7.5%) were nauseous, compared with 4 (10%) receiving ondansetron and 5 (12.5%) receiving droperidol. Conclusions: Ondansetron was effective in reducing the incidence of nausea and vomiting in patients receiving intrathecal morphine for Caesarean section.

Keywords

POSTOPERATIVE NAUSEA AND VOMITINGCAESAREAN SECTIONANAESTHESIA, SPINALANALGESICS, OPIOIDANTI-EMETICS, ondansetron, droperidolRANDOMIZED CONTROLLED TRIAL
Type
Original Article
Information
European Journal of Anaesthesiology , Volume 23 , Issue 8 , August 2006 , pp. 670 - 675
Copyright
© 2006 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Milner AR, Bogod DG, Harwood RJ. Intrathecal administration of morphine for elective Caesarean section. A comparison between 0.1 mg and 0.2 mg. Anaesthesia 1996; 51: 871–873.Google Scholar
Gerancher JC, Floyd H, Eisenach J. Determination of an effective dose of intrathecal morphine for pain relief after cesarean delivery. Anesth Analg 1999; 88: 346–351.Google Scholar
Yang T, Breen TW, Archer D et al. Comparison of 0.25 mg and 0.1 mg intrathecal morphine for analgesia after Caesarean section. Can J Anaesth 1999; 46: 856–860.Google Scholar
Palmer CM, Emerson S, Volgoropolous D et al. Dose-response relationship of intrathecal morphine for postcesarean analgesia. Anesthesiology 1999; 90: 437–444.Google Scholar
Cardoso MM, Carvalho JC, Amaro AR et al. Small doses of intrathecal morphine combined with systemic diclofenac for postoperative pain control after cesarean delivery. Anesth Analg 1998; 86: 538–541.Google Scholar
Swart M, Sewell J, Thomas D. Intrathecal morphine for caesarean section: an assessment of pain relief, satisfaction and side-effects. Anaesthesia 1997; 52: 373–377.Google Scholar
Sarvela J, Halonen P, Soikkeli A et al. A double-blinded, randomised comparison of intrathecal and epidural morphine for elective cesarean delivery. Anesth Analg 2002; 95: 436–440.Google Scholar
Dahl JB, Jeppesen IS, Jorgensen H et al. Intraoperative and postoperative analgesic efficacy and adverse effects of intrathecal opioids in patients undergoing cesarean section with spinal anesthesia: a qualitative and quantitative systematic review of randomized controlled trials. Anesthesiology 1999; 91: 1919–1927.Google Scholar
Gan TJ, Meyer T, Apfel CC et al. Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg 2003; 97: 62–71.Google Scholar
Fujii Y, Tanaka H, Toyooka H. Prevention of nausea and vomiting with granisetron, droperidol and metoclopramide during and after spinal anaesthesia for caesarean section: a randomized, double-blind, placebo-controlled trial. Acta Anaesthesiol Scand 1998; 42: 921–925.Google Scholar
Abouleish EI, Rashid S, Haque S et al. Ondansetron versus placebo for the control of nausea and vomiting during Caesarean section under spinal anaesthesia. Anaesthesia 1999; 54: 479–482.Google Scholar
Pan PH, Moore CH. Intraoperative antiemetic efficacy of prophylactic ondansetron versus droperidol for cesarean section patients under epidural anesthesia. Anesth Analg 1996; 83: 982–986.Google Scholar
Nortcliffe SA, Shah J, Buggy DJ. Prevention of postoperative nausea and vomiting after spinal morphine for Caesarean section: comparison of cyclizine, dexamethasone and placebo. Br J Anaesth 2003; 90: 665–670.Google Scholar
Tzeng JI, Wang JJ, Ho ST et al. Dexamethasone for prophylaxis of nausea and vomiting after epidural morphine for post-Caesarean section analgesia: comparison of droperidol and saline. Br J Anaesth 2000; 85: 865–868.Google Scholar
Yazigi A, Chalhoub V, Madi-Jebara S et al. Prophylactic ondansetron is effective in the treatment of nausea and vomiting but not on pruritus after cesarean delivery with intrathecal sufentanil–morphine. J Clin Anesth 2002; 14: 183–186.Google Scholar
Domino K, Anderson E, Polissar N et al. Comparative efficacy and safety of ondansetron, droperidol, metoclopramide for preventing postoperative nausea and vomiting: meta-analysis. Anesth Analg 1999; 88: 1370–1379.Google Scholar
Hill R, Lubarsky D, Phillips-Bute B et al. Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placebo. Anesthesiology 2000; 92: 931–933.Google Scholar
Peixoto AJ, Peixoto Filho AJ, Leaes LF et al. Efficacy of prophylactic droperidol, ondansetron or both in the prevention of postoperative nausea and vomiting in major gynaecological surgery. A prospective, randomized, double-blind clinical trial. Eur J Anaesthesiol 2000; 17: 611–615.Google Scholar
White PF. Prevention of postoperative nausea and vomiting – a multimodal solution to a persistent problem. N Engl J Med 2004; 350: 2511–2512.Google Scholar
White PF. Droperidol: a cost-effective antiemetic for over thirty years. Anesth Analg 2002; 95: 789–790.Google Scholar
Gan TJ, White PF, Scuderi PE et al. FDA ‘black box’ warning regarding use of droperidol for postoperative nausea and vomiting: is it justified? Anesthesiology 2002; 97: 287.Google Scholar
Habib AS, Gan TJ. Food and drug administration black box warning on the perioperative use of droperidol: a review of the cases. Anesth Analg 2003; 96: 1377–1379.Google Scholar
Kang FC, Tsai YC, Chang PJ et al. Subarachnoid fentanyl with diluted small-dose bupivacaine for cesarean section delivery. Acta Anaesthesiol Scand 1998; 36: 207–214.Google Scholar
Siddik-Sayyid SM, Aouad MT, Jalbout MI et al. Intrathecal versus intravenous fentanyl for supplementation of subarachnoid block during cesarean delivery. Anesth Analg 2002; 95: 209–213.Google Scholar
Powell RM, Buggy DJ. Ondansetron given before induction of anesthesia reduces shivering after general anesthesia. Anesth Analg 2000; 90: 1423–1427.Google Scholar
Charuluxananan S, Somboonviboon W, Kyokong O et al. Ondansetron for treatment of intrathecal morphine-induced pruritus after cesarean delivery. Reg Anesth Pain Med 2000; 25: 535–539.Google Scholar
Yeh HM, Chen LK, Lin CJ et al. Prophylactic intravenous ondansetron reduces the incidence of intrathecal morphine-induced pruritus in patients undergoing cesarean delivery. Anesth Analg 2000; 91: 172–175.Google Scholar